4
Changes in Ownership
LENZ Therapeutics, Inc. Filed Acc 0000899243-21-027013
Director acquired 49,876 shares (option exercise)
- Director acquired 8,126 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| JIMENEZ JOSEPH Director | 2021-01-14 | Option exercise | +49,876 | $0.30 | $14,963 | 153,815 | D |
| JIMENEZ JOSEPH Director | 2021-06-29 | Conversion | +8,126 | 161,941 | D | ||
| Derivatives | |||||||
| JIMENEZ JOSEPH Director | 2021-01-13 | Grant or award · Stock Option (right to buy) | +49,876 | 49,876 | D | ||
| JIMENEZ JOSEPH Director | 2021-01-14 | Option exercise · Stock Option (right to buy) | −49,876 | 0 | D | ||
| JIMENEZ JOSEPH Director | 2021-03-11 | Grant or award · Series B Preferred Stock | +19,763 | $5.06 | $100,001 | 19,763 | D |
| JIMENEZ JOSEPH Director | 2021-03-17 | Grant or award · Stock Option (right to buy) | +12,469 | 12,469 | D | ||
| JIMENEZ JOSEPH Director | 2021-06-29 | Conversion · Series B Preferred Stock | −19,763 | 0 | D | ||
Loading xslF345X03/doc4.xml…